Volume 26, Number 9—September 2020
Dispatch
Duration of Carbapenemase-Producing Enterobacteriaceae Carriage in Hospital Patients
Table
Demographics for 21 participants in study of duration of carbapenemase-producing Enterobacteriaceae carriage in hospital patients, Singapore*
Characteristic |
No. (%) |
Sex | |
M | 15 (71.4) |
F |
6 (28.6) |
Ethnicity | |
Chinese | 15 (71.4) |
Malay | 3 (14.3) |
Indian | 2 (9.5) |
Other |
1 (4.8) |
Ambulatory status | |
Independently performs ADL | 12 (57.1) |
Requires assistance in ADL | 4 (19.0) |
Wheelchair bound | 3 (14.3) |
Bed bound |
2 (9.5) |
Recent surgery† |
15 (71.4) |
Colonization or infection with another MDRO in the year preceding enrollment | 4 (19.0) |
Hospitalization in past year | 11 (52.4) |
Antibiotic intake during follow-up period | 13 (61.9) |
Readmission during follow-up period | 10 (47.6) |
Recent overseas travel | 13 (61.9) |
*Median age (interquartile range) was 60.0 (50.0–69.0) y; median Charlson Morbidity Index (interquartile range) 3.0 (2.0–5.0). ADL, activities of daily living; MDRO, multidrug-resistant organisms, including methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, carbapenem-resistant Enterobacteriaceae, carbapenem-resistant Acinetobacter baumanii, and carbapenem-resistant Pseudomonas aeruginosa, recorded from surveillance and clinical cultures taken in the year before study enrollment.
†Gastrointestinal surgeries (n = 7), skin and soft tissue surgeries (n = 4), neurosurgery (n = 2), removal of Tenckhoff catheter (n = 1), and urologic procedure (n = 1).
1These authors contributed equally to this article.